arrow
K

Keswadee Lapphra

faculty of medicine siriraj hospital
H指数:18
被引数:928

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence of acute diarrhoea among children (0–59 months old) in Thailand after introduction of rotavirus vaccine: a retrospective national database analysis (2014–2024)

泰国轮状病毒疫苗引入后0-59个月儿童急性腹泻的发病率:一项回顾性全国数据库分析(2014-2024)

2026-06-030
OAAI
Optimizing Diagnostic Protocols for Pulmonary Tuberculosis in Children: A Comparison of Diagnostic Yields From One-day, Two-day and Three-day Specimen Collection Strategies

优化儿童肺结核诊断方案:比较一日、两日和三日标本收集策略的诊断产出

2026-05-010
PRE
Corrigendum to “Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine” [Vaccine 62 (2025) 127558]

勘误: “活减毒四价登革热疫苗(TAK-003)与重组九价人乳头瘤病毒疫苗联合接种的免疫原性和安全性” [Vaccine 62 (2025) 127558]

Vaccine
IF3.5
2025-10-080
PRE
Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine

四价减毒活登革热疫苗(TAK-003)与重组九价人乳头瘤病毒疫苗同时接种时的免疫原性和安全性

Vaccine
IF3.5
2025-10-060
OAAI
Re-emerging outbreaks of chikungunya virus infections of increased severity: A single-center, retrospective analysis of atypical manifestations in hospitalized children during the 2019 outbreak in Bangkok, Thailand

查尔昆古病毒感染再发疫情的严重程度增加:泰国曼谷2019年疫情期间住院儿童中非典型表现的单一中心回顾性分析

2025-09-250
PRE
Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine

四价减毒活登革热疫苗(TAK-003)与重组九价人乳头瘤病毒疫苗联合接种的免疫原性和安全性

Vaccine
IF3.5
2025-07-310
OA
In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue fever
2024-09-230
OAAI
Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
2023-07-134
OAAI
Determining standardized causes of death of infants, children, and adolescents living with HIV in Asia

确定亚洲感染艾滋病毒的婴儿、儿童和青少年的标准化死亡原因

AIDS
IF3.1
2020-05-2012
OAAI
Use and Outcomes of Antiretroviral Monotherapy and Treatment Interruption in Adolescents With Perinatal HIV Infection in Asia

亚洲围产期HIV感染青少年抗逆转录病毒单药治疗和治疗中断的使用和结果

2019-11-010
OAAI
Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial
2018-11-0126
PREAI
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial
2018-01-0126
PREAI